Tessier Jeffrey M, Moore Billy, Putty Bradley, Gandhi Rajesh R, Duane Therese M
Department of Surgery, John Peter Smith Health Network , Fort Worth, Texas.
Surg Infect (Larchmt). 2016 Dec;17(6):720-723. doi: 10.1089/sur.2015.086. Epub 2016 Aug 8.
Data on antimicrobial prophylaxis for open fractures is limited, with many protocols based on expert recommendations. These protocols include aminoglycosides (AGs) for fractures with significant soft tissue injury, but these drugs are associated with acute kidney injury (AKI) in other settings; this risk has not been defined for open fracture prophylaxis.
We performed a retrospective study from May 2012 to October 2014 at our Level 1 trauma center. Patients with open fractures were evaluated for demographics, location/type of fracture, injury severity, and receipt of an AG. Outcomes included rates of AKI, infection, and mortality.
There were 167 patients with open fractures during the study period (119 males, mean age 42 ± 17 [standard deviation] years), with 80 (48%) receiving prophylactic gentamicin (AG+ group). The AG+ and AG- patients had similar fracture sites and Injury Severity Scores (ISSs) (12.6 ± 9.9 AG+ vs. 15.9 ± 13.2 AG-) but were more likely to have sustained blunt trauma (96% AG+ vs. 77%; p < 0.001) or received intravenous contrast medium ≤48 h from admission (75% AG+ vs. 56% AG-; p = 0.01). Gentamicin was not associated with AKI (odds ratio [OR] 0.22; 95% confidence interval [CI] 0.020-2.44; p = 0.22), whereas hypotension on admission (OR 10.7; 95% CI 1.42-80.93; p = 0.02) and ISS (OR 1.1; 95% CI 1.01-1.20; p = 0.02) were both associated with AKI. Only four fracture site infections were identified, three in the AG+ group and one in the AG- group (3.8% vs. 1.1%; p = 0.27). The mortality rate was greater in the AG- group (3.8% vs. 12.6%; p = 0.04).
Prophylactic gentamicin is not associated with AKI, whereas hypotension on admission and higher ISS were. The use of nephrotoxic agents, including aminoglycosides, should be restricted in open fracture patients presenting with hypotension or a high ISS.
开放性骨折抗菌药物预防的数据有限,许多方案基于专家建议。这些方案包括对伴有严重软组织损伤的骨折使用氨基糖苷类药物(AGs),但这些药物在其他情况下与急性肾损伤(AKI)相关;这种风险在开放性骨折预防中尚未明确。
我们于2012年5月至2014年10月在我们的一级创伤中心进行了一项回顾性研究。对开放性骨折患者进行人口统计学、骨折部位/类型、损伤严重程度以及是否接受AGs评估。结局指标包括AKI发生率、感染率和死亡率。
研究期间有167例开放性骨折患者(119例男性,平均年龄42±17[标准差]岁),其中80例(48%)接受了预防性庆大霉素治疗(AG+组)。AG+组和AG-组患者的骨折部位和损伤严重程度评分(ISS)相似(AG+组为12.6±9.9,AG-组为15.9±13.2),但更有可能遭受钝性创伤(AG+组为96%,AG-组为77%;p<0.001)或在入院后≤48小时接受静脉造影剂(AG+组为75%,AG-组为56%;p=0.01)。庆大霉素与AKI无关(比值比[OR]0.22;95%置信区间[CI]0.020-2.44;p=0.22),而入院时低血压(OR 10.7;95%CI 1.42-80.93;p=0.02)和ISS(OR 1.1;95%CI 1.01-1.20;p=0.02)均与AKI相关。仅发现4例骨折部位感染,AG+组3例,AG-组1例(3.8%对1.